Bristol-Myers Squibb Company
Utility Patent Applications

Last updated:

List of all Bristol-Myers Squibb Company patents 438 in total

Status Patent
Application
Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A BENZOTRIAZOLE MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR External link
Filling date: 6 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: IMMUNOMODULATORS External link
Filling date: 6 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: TREATMENT OF CANCER WITH ANTI-GITR AGONIST ANTIBODIES External link
Filling date: 6 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITIS C External link
Filling date: 6 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE AND/OR EPX External link
Filling date: 6 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE External link
Filling date: 6 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: USE OF ALKALINE WASHES DURING CHROMATOGRAPHY TO REMOVE IMPURITIES External link
Filling date: 6 Sep 2025 Issue date: 10 Sep 2020
Application
Utility: SUBSTITUTED BICYCLIC COMPOUNDS External link
Filling date: 6 Sep 2025 Issue date: 10 Sep 2020
Application
Utility: ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 10 Sep 2020
Application
Utility: FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS External link
Filling date: 6 Sep 2025 Issue date: 10 Sep 2020
Application
Utility: ALKENE COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS External link
Filling date: 6 Sep 2025 Issue date: 10 Sep 2020
Application
Utility: ADDITIVE SYSTEMS FOR USE IN PROTEIN PEGYLATION External link
Filling date: 6 Sep 2025 Issue date: 3 Sep 2020
Application
Utility: AMINOIMIDAZOPYRIDAZINES AS KINASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 3 Sep 2020
Application
Utility: VECTORS FOR VARIABLE REGION SEQUENCE SCREENING External link
Filling date: 6 Sep 2025 Issue date: 3 Sep 2020
Application
Utility: ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS External link
Filling date: 6 Sep 2025 Issue date: 27 Aug 2020
Application
Utility: CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS External link
Filling date: 6 Sep 2025 Issue date: 27 Aug 2020
Application
Utility: GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES External link
Filling date: 6 Sep 2025 Issue date: 20 Aug 2020
Application
Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING HETEROATOM-LINKED AROMATIC MOIETIES, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR External link
Filling date: 6 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: CARBAZOLE DERIVATIVES External link
Filling date: 6 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: PHENYLPYRROLIDINONE FORMYL PEPTIDE 2 RECEPTOR AGONISTS External link
Filling date: 6 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: THERAPEUTIC TREM-1 PEPTIDES External link
Filling date: 6 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: ONLINE BIOMASS CAPACITANCE MONITORING DURING LARGE SCALE PRODUCTION OF POLYPEPTIDES OF INTEREST External link
Filling date: 6 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS External link
Filling date: 6 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANTIBODY DIRECTED AGAINST CD28 External link
Filling date: 6 Sep 2025 Issue date: 6 Aug 2020
Application
Utility: FIBRONECTIN BASED SCAFFOLD PROTEINS External link
Filling date: 6 Sep 2025 Issue date: 6 Aug 2020
Application
Utility: METHODS OF TREATING TUMOR External link
Filling date: 6 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: SUBSTITUTED INDOLE COMPOUNDS USEFUL AS INHIBITORS OF TLR7/8/9 External link
Filling date: 6 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-- YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE External link
Filling date: 6 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONS External link
Filling date: 6 Sep 2025 Issue date: 23 Jul 2020
Application
Utility: METHODS OF TREATING TRANSPLANT REJECTION USING A DOMAIN ANTIBODY DIRECTED AGAINST CD40L External link
Filling date: 6 Sep 2025 Issue date: 23 Jul 2020
Application
Utility: TREATMENT OF HEMATOLOGIC MALIGNANCIES WITH AN ANTI-CXCR4 ANTIBODY External link
Filling date: 6 Sep 2025 Issue date: 23 Jul 2020
Application
Utility: 2-(1,1'-BIPHENYL)-1H-BENZODIMIDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS APELIN AND APJ AGONISTS FOR TREATING CARDIOVASCULAR DISEASES External link
Filling date: 6 Sep 2025 Issue date: 23 Jul 2020
Application
Utility: ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 23 Jul 2020
Application
Utility: CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS External link
Filling date: 6 Sep 2025 Issue date: 16 Jul 2020
Application
Utility: PROCESS FOR THE PREPARATION OF N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO[1,5-A][1- ,3,5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE External link
Filling date: 6 Sep 2025 Issue date: 16 Jul 2020
Application
Utility: METHODS OF TREATING AUTOIMMUNE DISEASE USING A DOMAIN ANTIBODY DIRECTED AGAINST CD40L External link
Filling date: 6 Sep 2025 Issue date: 9 Jul 2020
Application
Utility: IMMUNOMODULATORS External link
Filling date: 6 Sep 2025 Issue date: 9 Jul 2020
Application
Utility: ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS External link
Filling date: 6 Sep 2025 Issue date: 2 Jul 2020
Application
Utility: PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AGONISTS External link
Filling date: 6 Sep 2025 Issue date: 2 Jul 2020
Application
Utility: METHODS OF TREATING IMMUNE DISEASES BY ADMINISTERING ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40 External link
Filling date: 6 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTIBODY External link
Filling date: 6 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: ANTI-NKG2A ANTIBODIES AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: SUPRAMOLECULAR FILAMENTOUS ASSEMBLIES FOR PROTEIN PURIFICATION External link
Filling date: 6 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: CYCLOPROPYL UREA FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS External link
Filling date: 6 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: IP-10 ANTIBODIES AND THEIR USES External link
Filling date: 6 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR External link
Filling date: 6 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: ANTIBODIES AGAINST TIM3 AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: IMPROVED METHODS OF ANTIBODY PRODUCTION THAT MINIMIZE DISULFIDE BOND REDUCTION External link
Filling date: 6 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: SUBSTITUTED ISOQUIONLINE DERIVATIVES AS IMMUNOMUDULATORS External link
Filling date: 6 Sep 2025 Issue date: 11 Jun 2020

Showing 250 to 300 of 438 patents.